COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 962: Articles 9611-9620  | Next

Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients
Blanco, I., Violan, C., Suner, C., Garcia-Prieto, J., Argerich, M. J., Rodriguez-Illana, M., Moreno, N., Cardona, P.-J., Blanco, A., Toran-Montserrat, P., Clotet, B., Bonet, J. M., Prat, N.
10.1101/2022.01.20.22269539 — Posted: 2022-01-23
Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis
Lee, T. C., Murthy, S., Del Corpo, O. C., Senecal, J., Butler-Laporte, G., Sohani, Z. N., Brophy, J. M., McDonald, E. G.
10.1101/2022.01.22.22269545 — Posted: 2022-01-23
ESCPE-1 Mediates Retrograde Endosomal Sorting of the SARS-CoV-2 Host Factor Neuropilin-1
Simonetti, B., Daly, J. L., Simon-Gracia, L., Klein, K., Weeratunga, S., Anton-Plagaro, C., Tobi, A., Hodgson, L., Lewis, P., Heesom, K. J., Shoemark, D. K., Davidson, A. D., Collins, B. M., Teesalu, T., Yamauchi, Y., Cullen, P. J.
10.1101/2022.01.20.477115 — Posted: 2022-01-22
Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine
Xia, H., Zou, J., Kurhade, C., Cai, H., Yang, Q., Cutler, M., Cooper, D., Muik, A., Jansen, K. U., Xie, X., Swanson, K. A., Shi, P.-Y.
10.1101/2022.01.21.476344 — Posted: 2022-01-22
Broadly-recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
Becerra-Artiles, A., Calvo-Calle, J. M., Co, M., Nanaware, P., Cruz, J., Weaver, G. C., Lu, L., Forcini, C., Finberg, R. W., Moormann, A., Stern, L. J.
10.1101/2022.01.20.477107 — Posted: 2022-01-22
In Silico Analysis Of The Effects Of Omicron Spike Amino Acid Changes On The Interactions With Human ACE2 Receptor And Structurally Characterized Complexes With Human Antibodies
D'Arminio, N., Giordano, D., Scafuri, B., Biancaniello, C., Petrillo, M., Facchiano, A., Marabotti, A.
10.1101/2022.01.20.477105 — Posted: 2022-01-22
Comprehensive Evaluation of ACE2-Fc Combination with Neutralization Antibody on Broad Protection against SARS-CoV-2 and Its Variants
Tang, H., Ke, Y., Ma, H., Han, L., Wang, L., Zong, H., Yuan, Y., Wang, Z., He, Y., Chang, Y., Wang, S., Liu, J., Yue, Y., Xu, W., Zhang, X., Wang, Z., Yang, L., Chen, H., Bian, Y., Zhang, B., Liao, Y., Yin, H., Chen, Y., Zhang, E., Zhang, X., Jiang, H., Xie, Y., Gilly, J., Wu, M., Sun, T., Zhu, J.
10.1101/2022.01.17.475291 — Posted: 2022-01-22
Prior health-related behaviours in children (2014-2020) and association with a positive SARS-CoV-2 test during adolescence (2020-2021): a retrospective cohort study using survey data linked with routine health data in Wales, UK
Marchant, E., Lowthian, E., Crick, T., Griffiths, L., Fry, R., Dadaczynski, K., Okan, O., James, M., Cowley, L., Torabi, F., Kennedy, J., Akbari, A., Lyons, R., Brophy, S.
10.1101/2022.01.21.22269651 — Posted: 2022-01-22
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassay
Johnson, J. M., Fernandes, S. C., Wuelfing, D. L., Baillargeon, A. R., MacLure, E. L., Hwang, S., Ball, A. J., Cheedarla, N., Verkerke, H. P., Potlapalli, S., McLendon, K. B., Neish, A., O'Sick, W., Roback, J. D., Wilson, D. H., Mattoon, D.
10.1101/2022.01.21.22269165 — Posted: 2022-01-22
Using Survey Data to Estimate the Impact of the Omicron Variant on Vaccine Efficacy against COVID-19 Infection
Rufino, J., Baquero, C., Frey, D., Glorioso, C. A., Ortega, A., Rescic, N., Roberts, J. C., Lillo, R. E., Menezes, R., Champati, J. P., Fernandez Anta, A.
10.1101/2022.01.21.22269636 — Posted: 2022-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).